Oral Genome is a health technology company that turns saliva into actionable wellness insights. Our rapid chairside platform helps dental and healthcare teams assess multiple oral and systemic health indicators in 10–15 minutes, without a laboratory or costly analyzer. We serve dental practices, healthcare organizations, payers, and researchers. Oral Genome exists to connect oral health with whole-body health, helping providers identify potential risks earlier, improve patient education and treatment acceptance, and support more preventive, connected care.

I am Dr. Tina Saw, a dentist, entrepreneur, and the founder and CEO of Oral Genome. My entrepreneurial journey began with a simple belief: the mouth can reveal important insights about a person’s overall health, yet dentistry and medicine have traditionally operated in separate worlds. I founded Oral Genome to help bridge that gap.

We developed a chairside saliva-screening platform that gives dental and healthcare teams actionable wellness insights in minutes—without requiring a laboratory or expensive equipment. What began as an idea has grown into a company working with dental organizations, healthcare partners, researchers, payers, and practices in the United States and internationally.

Building Oral Genome has required persistence, creativity, and the courage to keep moving forward through the uncertainty that comes with creating something new. As a dentist, founder, and mother, I have learned how to lead with both resilience and empathy. My goal is not simply to build a successful saliva-testing company, but to create a new model of preventive care—one that helps identify risks earlier, improves patient conversations and treatment acceptance, and better connects oral health with whole-body health.